Pulmonary rehabilitation and interstitial lung disease: Aiding the referral decision

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 33, Issue 3, 2013, Pages 189-195

  Johnson Warrington, Vicki ^a   Williams, Johanna ^a   Bankart, John ^b   Steiner, Michael ^a   Morgan, Mike ^a   Singh, Sally ^a,c  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c Institute for Clean Growth and Future Mobility   (United Kingdom)

Author keywords

interstitial lung disease; oxygen; pulmonary rehabilitation

Indexed keywords

AGED; CHRONIC RESPIRATORY QUESTIONNAIRE DYSPNEA; CHRONIC RESPIRATORY QUESTIONNAIRE EMOTION; CHRONIC RESPIRATORY QUESTIONNAIRE FATIGUE; CHRONIC RESPIRATORY QUESTIONNAIRE MASTERY; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ENDURANCE SHUTTLE WALK TEST; EXERCISE; EXERCISE TEST; FEMALE; FIBROSING ALVEOLITIS; HOME OXYGEN THERAPY; HUMAN; INCREMENTAL SHUTTLE WALK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD REVIEW; MORTALITY; OBSERVATIONAL STUDY; OUTPATIENT; PATIENT REFERRAL; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; COHORT STUDIES; DECISION MAKING; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REFERRAL AND CONSULTATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84877769501     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e31828db112     Document Type: Review

References (37)

1. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63 (suppl 5): v1-v58.
2. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis. 2008; 3: 8.
3. Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008; 102: 1675-1680.
4. Naji NA, Connor MC, Donnelly SC, McDonnell TJ. Effectiveness of pulmonary rehabilitation in restrictive lung disease. J Cardiopulm Rehabil. 2006; 26: 237-243.
5. Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest. 2009; 135: 442-447.
6. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006; 173: 1390-1413.
7. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183: 788-824.
8. Kozu R, Senjyu H, Jenkins SC, Mukae H, Sakamoto N, Kohno S. Differences in response to pulmonary rehabilitation in idio-pathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration. 2011; 81: 196-205.
9. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008; 63: 549-554.
10. Holland AE, Hill CJ. New horizons for pulmonary rehabilitation. Phys Ther Rev. 2011; 16: 3-9.
11. Markovitz GH, Cooper CB. Rehabilitation in non-COPD: mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease. Chron Respir Dis. 2010; 7: 47-60.
12. Hansen JE, Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest. 1996; 109: 1566-1576.
13. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-Minute Walk Test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003; 168: 1084-1090.
14. Salhi B, Troosters T, Behaegel M, Joos G, Derom E. Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest. 2010; 137: 273-279.
15. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005; 142 (12)(Pt 1): 963-967.
16. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161 (2)(Pt 1): 646-664.
17. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003; 168: 538-542.
18. Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J. 1996; 9: 431-435.
19. Berger ML, Mamdani M, Atkins D, Johnson ML. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part I. Value Health. 2009; 12: 1044-1052.
20. Tinetti ME, Studenski SA. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med. 2011; 364: 2478-2481.
21. Williams JE, Singh SJ, Sewell L, Guyatt GH, Morgan MD. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax. 2001; 56: 954-959.
22. Zigmond A, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361-370.
23. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992; 47: 1019-1024.
24. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax. 1999; 54: 213-222.
25. British Thoracic Society Working Group. Clinical Component for the Home Oxygen Service in England and Wales. 2006. http://www.brit-thoracic.org.uk/ Portals/0/Clinical%20Information/Home%20Oxygen%20Service/ clinical%20adultoxygenjan06.pdf. Accessed February 11, 2013.
26. Members of the BTS Standards of Care Subcommittee on Pulmonary Rehabilitation. Domiciliary Oxygen Therapy Services: Clinical Guidelines and Advice for Prescribers. Summary of a report of the Royal College of Physicians. London, UK: Royal College of Physicians of London; 1999.
27. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007; 131 (5) (suppl): 4S-42S.
28. Wijkstra PJ, TenVergert EM, van der Mark TW, et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax. 1994; 49: 468-472.
29. du Bois RM, Weycker D, Albera C, et al. Six-Minute-Walk Test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011; 183: 1231-1237.
30. Singh SJ, Jones PW, Evans R, Morgan MD. Minimum clinically important improvement for the incremental shuttle walking test. Thorax. 2008; 63: 775-777.
31. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10: 407-415.
32. Morgan MDL. Pulmonary rehabilitation. Thorax. 2001; 56: 827-834.
33. Kortianou EA, Nasis IG, Spetsioti ST, Daskalakis AM, Vogiatzis I. Effectiveness of interval exercise training in patients with COPD. Cardiopulm Phys Ther J. 2010; 21: 12-19.
34. Ringbaek T, Martinez G, Brondum E, Thogersen J, Morgan M, Lange P. Shuttle walking test as predictor of survival in chronic obstructive pulmonary disease patients enrolled in a rehabilitation program. J Cardiopulm Rehabil Prev. 2010; 30: 409-414.
35. Gilbert CR, Smith CM. Advanced lung disease: quality of life and role of palliative care. Mt Sinai J Med. 2009; 76: 63-70.
36. Daniels CE, Ryu JH. Treatment of idiopathic pulmonary fibro-sis. Semin Respir Crit Care Med. 2006; 27: 668-676.
37. Holland AE, Hill CJ, Glaspole I, Goh N, McDonald CF. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med. 2011; 106: 429-435.